The product is viable and the tests are going well. That combined with SHAW's interest and Roberts backing is all one needs to know. A viable product that is verified with tests... That is the biggest hurdle, its rate limiting step. Everything else is a pretty simple matter. Contrary to Marcus' repeated statements that Raphael cannot bring this to the market, if CRAM works a child can bring this to the market.
Market Data 
Markets 
